These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 27676319

  • 1. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A, Linecker M, Kron P, Györi G, De Oliveira ML, Müllhaupt B, Clavien PA, Dutkowski P.
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [Abstract] [Full Text] [Related]

  • 2. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A, Kalisvaart M, Scalera I, Laing RW, Mergental H, Mirza DF, Perera T, Isaac J, Dutkowski P, Muiesan P.
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [Abstract] [Full Text] [Related]

  • 3. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [Abstract] [Full Text] [Related]

  • 4. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N, Kelly B, Soltys K, Squires JE, Vockley J, Shellmer DA, Strauss K, McKiernan P, Ganoza A, Sindhi R, Bond G, Mazariegos G, Khanna A.
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y, Wang Q, Yang J, Yan L.
    PLoS One; 2015 Nov; 10(9):e0136604. PubMed ID: 26378786
    [Abstract] [Full Text] [Related]

  • 6. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE, Perkins JD, Reyes JD, Montenovo MI.
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [Abstract] [Full Text] [Related]

  • 7. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM.
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [Abstract] [Full Text] [Related]

  • 8. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 9. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, Hernandez-Alejandro R.
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [Abstract] [Full Text] [Related]

  • 10. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
    Godfrey EL, Malik TH, Lai JC, Mindikoglu AL, Galván NTN, Cotton RT, O'Mahony CA, Goss JA, Rana A.
    Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
    [Abstract] [Full Text] [Related]

  • 11. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW.
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [Abstract] [Full Text] [Related]

  • 12. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP, Lee DD, Croome S, Nakhleh RE, Abader Sedki Senada P, Livingston D, Yataco M, Taner CB.
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [Abstract] [Full Text] [Related]

  • 13. Artificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multi-center study.
    Yu YD, Lee KS, Man Kim J, Ryu JH, Lee JG, Lee KW, Kim BW, Kim DS, Korean Organ Transplantation Registry Study Group.
    Int J Surg; 2022 Sep; 105():106838. PubMed ID: 36028137
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
    Matoba D, Noda T, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, Tomimaru Y, Takahashi H, Doki Y, Eguchi H.
    Transplant Proc; 2023 May; 55(4):893-897. PubMed ID: 37120341
    [Abstract] [Full Text] [Related]

  • 15. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS, Goja S, Yadav SK, Tamang TY, Rastogi A, Bhangui P, Thiagrajan S, Raut V, Babu RY, Saigal S, Saraf N, Choudhary NS, Vohara V.
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [Abstract] [Full Text] [Related]

  • 16. Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status.
    Grąt M, Wronka KM, Patkowski W, Stypułkowski J, Grąt K, Krasnodębski M, Masior Ł, Lewandowski Z, Krawczyk M.
    Dig Dis Sci; 2016 Feb; 61(2):626-35. PubMed ID: 26499986
    [Abstract] [Full Text] [Related]

  • 17. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 18. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P, Oberkofler CE, Slankamenac K, Puhan MA, Schadde E, Müllhaupt B, Geier A, Clavien PA.
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [Abstract] [Full Text] [Related]

  • 19. Adult Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure in High-Model for End-Stage Liver Disease Score Patients.
    Moon DB, Lee SG, Kang WH, Song GW, Jung DH, Park GC, Cho HD, Jwa EK, Kim WJ, Ha TY, Kim HJ.
    Am J Transplant; 2017 Jul; 17(7):1833-1842. PubMed ID: 28097804
    [Abstract] [Full Text] [Related]

  • 20. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.